Zinecard

Active Ingredient(s): Dexrazoxane
FDA Approved: * May 26, 1995
Pharm Company: * PHARMACIA AND UPJOHN
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Zinecard Overview

Dexrazoxane hydrochloride (Zinecard, Cardioxane) is a cardioprotective agent. It was discovered by Kurt Hellmann in 1972. The IV administration of dexrazoxane is in acidic condition with HCl adjusting the pH.[1] Uses Dexrazoxane has been used to protect the heart against the cardiotoxic side effects of chemotherapeutic drugs such as anthracyclines,[2] such as daunorubicin or doxorubicin or other chemotherapeutic agents.[3] However, in July 20...

Read more Zinecard Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Dexrazoxane

Recent Zinecard Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Dexrazoxane
  • Injection: 250mg, 250mg/vial, 500mg, 500mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Zinecard: (2 results)

Sorted by National Drug Code
  • 0013-8717 Zinecard 250 mg/25ml Intravenous Injection, Powder, Lyophilized, for Solution by Pharmacia and Upjohn Company
  • 0013-8727 Zinecard 500 mg/50ml Intravenous Injection, Powder, Lyophilized, for Solution by Pharmacia and Upjohn Company

Other drugs which contain Dexrazoxane or a similar ingredient: (2 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 12 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA